Efficacy of PD-1/PD-L1 inhibitors combined with anti-VEGF/TKIs and TACE in uHCC: a meta-analysis

Abstract

Background This study evaluated the efficacy of transarterial chemoembolization (TACE) combined with anti-vascular endothelial growth factor (VEGF)/tyrosine kinase inhibitors (TKIs) and programmed cell death protein 1 (PD-1)/programmed cell death protein ligand 1 (PD-L1) inhibitors in the treatment of unresectable hepa

The paper